Fetal RHD Screening in RH1 Negative Pregnant Women: Experience in Switzerland

RH1 incompatibility between mother and fetus can cause hemolytic disease of the fetus and newborn. In Switzerland, fetal RHD genotyping from maternal blood has been recommended from gestational age 18 onwards since the year 2020. This facilitates tailored administration of RH immunoglobulin (RHIG) o...

Descripción completa

Detalles Bibliográficos
Autores principales: Schimanski, Bernd, Kräuchi, Rahel, Stettler, Jolanda, Lejon Crottet, Sofia, Niederhauser, Christoph, Clausen, Frederik Banch, Fontana, Stefano, Hodel, Markus, Amylidi-Mohr, Sofia, Raio, Luigi, Abbal, Claire, Henny, Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604374/
https://www.ncbi.nlm.nih.gov/pubmed/37893020
http://dx.doi.org/10.3390/biomedicines11102646

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604374/
https://www.ncbi.nlm.nih.gov/pubmed/37893020
http://dx.doi.org/10.3390/biomedicines11102646

Ejemplares similares